COVID-19 Resources for National HIV Programs
On March 11, 2020, the WHO declared COVID-19 a global pandemic. There is no specific data on COVID-19 and HIV yet. However, individuals who are immunosuppressed are at known higher risk from the novel coronavirus. Because of this, immediate precautions are needed by Ministries of Health (MOHs) to prevent COVID-19 spread and ensure continuity of essential HIV services in the event of an outbreak. To support COVID-19 preparedness, CHAI will update this landing page on a regular basis with a number of key resources to guide MOHs as they support PLHIV to safely access essential services during the pandemic.
The key principles for HIV programs in preparing for the pandemic are to:
Prepare contingency plans and take actions today in advance of an outbreak
Ensure continuity of antiretroviral (ARV) supply and essential HIV services
Identify opportunities to decongest health facilities and limit exposure of the novel coronavirus to PLHIV (e.g., through use of multi-month scripting).
Key CHAI Tools and Resources
Additional Global Guidance and Resources:
If there are resources you would like to share or tools you would like to see posted on the Toolkit, please reach out to HIVToolkit@clintonhealthaccess.org.
The HIV New Product Introduction Toolkit provides Ministries of Health (MoHs) and implementing partners with the tools necessary to evaluate the adoption and introduction of new products in their local context. The toolkit includes a wide-range of information, tools, and resources spanning the entire chain of product introduction including product adoption, forecasting, procurement, facility phase-in, and supply planning and monitoring, ensuring that products reach those in need of them.
The graphic above outlines the key focus areas that should be considered during this process. In practice, many of these steps take place concurrently and are not always consecutive. This toolkit is not meant to be prescriptive, but rather provide a framework for ministries and implementing partners to evaluate product adoption and provide tools to plan the introduction of new products. While this framework focuses on ARVs, it can be applicable to other health commodities.
What is the purpose of this toolkit?
With the availability and inclusion in WHO treatment guidelines of new, optimal antiretrovirals (ARVs), which are more efficacious, tolerable and cheaper, as well as optimal paediatric formulations which improve upon limited treatment options for children, national HIV treatment programs are preparing for big shifts in treatment guidelines and the ARV formulary. Accelerating access to the best available treatment options not only better serves the needs of patients, but also supports significant treatment scale-up, saves money, and achieves public health goals. Making new products widely accessible to people who can benefit from them requires high levels of planning, coordination and targeted implementation. This toolkit leverages experience from CHAI's long-term partnerships with Ministries of Health (MoHs) on new product introduction to provide tools and resources for national programs, partners and community members to evaluate, plan and execute effective transition strategies.
The HIV New Product Introduction Guide accompanies the toolkit and provides a guide for the user through the key steps of the New Product Introduction Framework, including key activities, considerations and supporting tools and resources available on the toolkit. A comprehensive checklist for all steps in the New Product Introduction Framework has also been developed to guide Ministries of Health and partners when introducing new ARVs in-country.
The toolkit is designed to evolve based on contribution from all those involved in product introduction efforts as new experiences, best practices and lessons learned are generated, and new or updated tools and resources are developed across MoHs and partners. We welcome submission of additional resources to build the repository. For more information on the toolkit or to contribute resources, contact: HIVToolkit@clintonhealthaccess.org.
The development of this website and some of the content has been funded by Unitaid through the CHAI-Unitaid Optimal ARV project. Learn more about the CHAI-Unitaid collaboration here